Related Experiment Video
Updated: Aug 11, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Pulmonary Hypertension and Operative Risk in Mitral Valve and Coronary Surgery
Robert B Hawkins1, Raymond J Strobel2, J Hunter Mehaffey2
1Department of Cardiac Surgery, University of Michigan, Ann Arbor, Michigan.
Insights
Pulmonary hypertension (PHT) poses a lower risk for mitral valve surgery than for coronary artery bypass grafting (CABG). This finding highlights the need for optimized perioperative care for PHT patients undergoing cardiac procedures.
Area of Science:
- Cardiology
- Cardiac Surgery
- Pulmonary Hypertension
Background:
- Pulmonary hypertension (PHT) is a known risk factor for coronary artery bypass grafting (CABG).
- The impact of PHT on outcomes following mitral valve operations is less understood.
- This study investigates the association between PHT and surgical risk in mitral valve operations compared to CABG.
Purpose of the Study:
- To test the hypothesis that PHT is associated with a lower risk during mitral valve operations compared to CABG.
- To analyze the association of pulmonary artery systolic pressure (PASP) with operative outcomes in patients undergoing mitral valve or CABG procedures.
- To identify potential differences in risk stratification for patients with PHT undergoing different cardiac surgeries.
Main Methods:
- Utilized data from a regional Society of Thoracic Surgeons (STS) database (2011-2019).
- Included patients undergoing isolated mitral valve or CABG operations.
- Stratified patients by pulmonary artery systolic pressure (PASP) and used hierarchical regression modeling, adjusting for STS predicted risk scores.
Main Results:
- Mitral valve surgery patients had higher mean STS risk of mortality and median PASP compared to CABG patients.
- Increased PASP was independently associated with operative mortality and major morbidity in both groups.
- A 10-mmHg increase in PASP was associated with lower odds of morbidity, mortality, and ICU time in mitral patients compared to CABG patients (P < 0.0001).
Conclusions:
- Despite higher preoperative pulmonary artery pressures, PHT was linked to lower risk for mitral valve surgery outcomes compared to CABG.
- Further research is needed to optimize perioperative management of patients with PHT.
- Improved understanding and care strategies for PHT patients undergoing cardiac surgery are essential.
Introduction:
Pulmonary hypertension (PHT) is a known risk factor for coronary artery bypass grafting (CABG), though less well understood for valve operations. We hypothesized PHT is associated with lower risk during mitral valve operations compared to CABG.
Methods:
Patients undergoing isolated mitral valve or CABG operations (2011-2019) in a regional Society of Thoracic Surgeons (STS) database were stratified by pulmonary artery systolic pressure (PASP). The association of PASP by procedure type was assessed by hierarchical regression modeling, adjusting for STS predicted risk scores.
Results:
Of the 2542 mitral and 11,059 CABG patients, the mitral population had higher mean STS risk of mortality (3.6% versus 2.4%, P < 0.0001) and median PASP (42 mmHg versus 32 mmHg, P < 0.0001). PASP was independently associated with operative mortality and major morbidity in both mitral and CABG patients. However, for mitral patients a 10-mmHg increase in PASP was associated with lower odds of morbidity (odds ratio: 1.06 versus 1.13), mortality (odds ratio: 1.11 versus 1.18) and intensive care unit time (4.3 versus 7.6 h) compared with CABG patients (interaction terms P < 0.0001). Among mitral patients, median PASP was higher in stenotic versus regurgitant disease (57 mmHg versus 40 mmHg, P < 0.0001). However, there was no differential association of PASP on morbidity or mortality (interaction terms P > 0.05).
Conclusions:
Although mitral surgery patients tend to have higher preoperative pulmonary artery pressures, PHT was associated with a lower risk for mitral outcomes compared with CABG. Further research on the management and optimization of patients with PHT perioperatively is needed to improve care for these patients.
More Related Videos
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis III: Medical Management
Mitral Stenosis I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis IV: Nursing Management
Mitral Regurgitation IV: Nursing Management

